Conexeu Sciences (CNXU)
Conexeu Sciences Inc. develops collagen-based regenerative tissue scaffold products for applications in medical aesthetics and tissue repair. The company provid...
- Open
- 5.490
- High
- 5.750
- Low
- 5.350
- Prev. Close
- 5.560
- Volume
- 83.15K
- Turnover
- 458.10K
- Avg Price
- 5.509
- Bid/Ask Ratio
- 98.68%
- Amplitude
- 7.19%
- 52wk High
- 18.792
- Volume Ratio
- 4.51
- Turnover Ratio
- --
Conexeu Sciences Analyst Rating
View moreForecast & Rating
Jun 22, 2026Price forecast
$20.00259.71%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- PR Newswire · 1 day ago, 03:37 PM
A Wave of Weight-Loss Drugs Is Quietly Creating a Multi-Billion-Dollar Opportunity That Aesthetic Medicine Is Racing to Capture
- PUBT · 2 days ago, 12:32 PM
Conexeu Sciences to present at Nasdaq/LD Micro Summit Series
- PUBT · Aug 18 at 12:55 PM
Conexeu says CXU preclinical program completes 12-month P..O.F. phase, meets objectives
- PUBT · Aug 11 at 12:32 PM
Conexeu Sciences CMO presents on extracellular matrix role in tissue regeneration at Laser & Cosmetic Surgery symposium
- rttnews · Jul 16 at 03:42 AM
Top Biotech Gainers: APLM Climbs 22%; IOVA, RCEL On Watch; MANE Gains On Hair Loss Data
